CVS Health Corp (CVS) Peer Comparison
$90.79
$0.46
(0.51%)
As on 30-Oct-2026 13:42EDT
Market cap
$115,529 Mln
Revenue (TTM)
$415,086 Mln
P/E Ratio
23.8
P/B Ratio
1.4
Div. Yield
3 %
Edit
| CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
115,529 | 102,446 | 58,227 | 29,895 | 27,794 |
Revenue ($ Mln) |
415,086 | 78,701 | 2,707 | 14,595 | 11,841 |
Net Profit ($ Mln) |
4,906.00 | 6,776.00 | -192.35 | 1,004.00 | 1,129.00 |
Net Margin (%) |
1.18 | 8.61 | -7.11 | 6.88 | 9.53 |
RoE (%) |
6.34 | -- | -10.89 | 11.42 | 14.38 |
Price to Earnings |
23.77 | 15.86 | -- | 30.18 | 25.08 |
Price-To-Book |
1.44 | 291.34 | 17.64 | 3.31 | 3.66 |
Income Statement ($ Mln)
| CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
415,086.00 | 78,701.00 | 2,707.08 | 14,594.50 | 11,841.00 |
|
Cost of Revenue
|
356,340.00 | 61,631.00 | 939.25 | 10,515.60 | 7,916.00 |
|
Gross Profit
|
55,362.00 | 31,374.00 | 1,495.49 | 3,732.50 | 3,523.00 |
|
Operating Expenses
|
50,458.00 | 55,312.00 | 2,057.50 | 2,456.00 | 2,197.00 |
|
Operating Profit (EBIT)
|
8,288.00 | 12,072.00 | -289.67 | 1,622.90 | 1,728.00 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
5,787.00 | 9,823.00 | -252.70 | 1,224.70 | 1,499.00 |
|
Provision for Tax
|
916.00 | 2,024.00 | -60.36 | 219.60 | 342.00 |
|
Profit after Tax (Net Income)
|
4,906.00 | 6,776.00 | -192.35 | 1,004.00 | 1,129.00 |
|
Minority Interest
|
5.00 | -1,023.00 | 0.00 | -0.80 | -51.00 |
|
Consolidated Profit
|
-1,032.00 | 1,878.00 | 0.00 | 164.70 | 245.00 |
Liabilities ($ Mln)
| CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
79,702.00 | -8,077.00 | 1,821.50 | 8,847.80 | 7,632.00 |
|
Minority Interest
|
5.00 | -1,023.00 | 0.00 | -0.80 | -51.00 |
|
Non-Current Liabilities
|
86,828.00 | 48,272.00 | 282.80 | 7,241.10 | 7,356.00 |
|
Current Liabilities
|
87,041.00 | 19,779.00 | 553.20 | 2,819.60 | 1,834.00 |
|
Total Liabilities
|
261,064.00 | 60,720.00 | 2,508.04 | 18,392.70 | 16,225.00 |
Assets ($ Mln)
| CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
178,422.00 | 47,233.00 | 998.55 | 14,958.40 | 14,104.00 |
|
Current Assets
|
75,346.00 | 16,219.00 | 1,658.95 | 3,966.20 | 3,117.00 |
|
Total Assets
|
261,064.00 | 60,720.00 | 2,508.04 | 18,392.70 | 16,225.00 |
|
Total Debt*
|
76,306.00 | 52,426.00 | 238.49 | 6,775.90 | 6,285.00 |
|
Net Current Assets
|
-11,695.00 | -3,560.00 | 1,105.75 | 0.00 | 1,283.00 |
Cashflow ($ Mln)
| CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
10,639.00 | 12,636.00 | 215.30 | 1,640.50 | 1,886.00 |
|
Cash Flow from Investing Activities
|
-5,871.00 | -4,988.00 | -132.21 | -1,194.00 | -631.00 |
|
Cash from Financing Activities
|
-4,940.00 | -8,550.00 | 47.46 | -1,457.00 | -1,388.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
1.08 | 14.79 | -12.58 | 5.63 | 7.10 |
|
ROE (%)
|
6.34 | -612.27 | -10.89 | 11.42 | 14.38 |
|
ROA (%)
|
1.42 | 8.42 | -7.19 | 4.59 | 6.04 |
|
EBIT Margin (%)
|
2.14 | 15.45 | -9.03 | 9.93 | 14.51 |
|
Net Margin (%)
|
1.18 | 8.61 | -7.11 | 6.88 | 9.53 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
7.36 | 5.82 | 37.82 | 6.02 | 9.13 |
|
EBIT Growth (%)
|
-6.91 | 5.76 | 0.99 | 8.72 | 8.87 |
|
Net Profit Growth (%)
|
8.28 | 6.81 | 24.05 | 17.40 | 16.51 |
|
EPS Growth (%)
|
6.23 | 17.46 | 29.22 | 19.83 | 17.55 |
|
Book Value Growth (%)
|
1.96 | -317.59 | 39.14 | 4.35 | 6.09 |
Valuation Ratios
| CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
57.32 | 15.88 | -150.47 | 23.81 | 19.59 |
|
Price / Book Value
|
1.44 | 291.34 | 18.29 | 3.31 | 3.66 |
|
Dividend Yield (%)
|
2.96 | 0.64 | -- | 0.80 | 1.34 |
|
EV/EBITDA
|
14.80 | 9.44 | -138.12 | 16.95 | 14.89 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.75 | -5.25 | 0.00 | 0.00 | 0.73 |
|
Short term debt to equity ratio
|
0.05 | -1.00 | 0.05 | 0.09 | 0.03 |
|
Current Ratio
|
0.87 | 0.82 | 3.00 | 1.41 | 1.70 |
|
Quick Ratio
|
0.66 | 0.74 | 2.85 | 1.22 | 1.58 |
|
Interest Coverage
|
2.87 | 5.16 | -24.33 | 6.32 | 6.90 |
Operating Efficiency Ratios
| CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
9.71 | 14.62 | 15.59 | 17.53 | 14.46 |
|
Asset Turnover
|
1.20 | 0.98 | 1.01 | 0.67 | 0.63 |
|
Receivable days
|
34.63 | 52.22 | 48.36 | 57.04 | 44.88 |
|
Inventory Days
|
19.68 | 14.00 | 25.50 | 18.37 | 9.17 |
|
Payable days
|
39.65 | 36.90 | 15.34 | 30.68 | 45.88 |
|
Cash Conversion Cycle
|
14.66 | 29.32 | 58.52 | 44.73 | 8.17 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
